ir.fatetherapeutics.com Open in urlscan Pro
2a02:26f0:3500:18::1724:a29c  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form data-block-uuid="a28b4145-275a-4fd1-aa93-e4664ddca384" action="/search" method="get" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-search form-item-query js-form-item-query form-no-label">
    <input type="search" name="query" size="60" maxlength="128" placeholder="Search Investors" class="form-search required" required="required" aria-required="true">
  </div>
  <input type="submit" name="op" value="Search" class="button button--primary js-form-submit form-submit">
</form>

GET /search

<form class="views-exposed-form" data-drupal-selector="views-exposed-form-search-page-1" action="/search" method="get" id="views-exposed-form-search-page-1" accept-charset="UTF-8" data-drupal-form-fields="edit-query">
  <div class="form--inline clearfix">
    <div class="form-item js-form-item js-form-type-textfield form-type-textfield form-item-query">
      <label for="edit-query"></label>
      <input data-drupal-selector="edit-query" type="text" id="edit-query" name="query" value="" size="30" maxlength="128" class="form-text" placeholder="Search Investor">
    </div>
    <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit-search" type="submit" id="edit-submit-search" value="Search"
        class="button js-form-submit form-submit">
    </div>
  </div>
</form>

Text Content

Skip to main navigation


FATE THERAPEUTICS

0
Primary Menu Skip to content
 * About Us
   * Our Mission
   * Our Cells of Interest
   * Management
   * Board of Directors
 * Pipeline
   * Overview
   * Immuno-Oncology Candidates
     * FT500
     * FT516
     * FT596
     * FT538
     * FT576
     * FT819
   * Immuno-Regulation Candidates
     * ProTmune™
     * FT301
 * Science
   * Ex Vivo Cell Modulation
   * iPSC Platform
   * Manufacturing
   * Publications
 * Collaborations
 * Join Our Team
   * Career Opportunities
   * Vision, Mission, Values
   * Working at Fate
 * Investors
   * Overview
   * Press Releases
   * Events & Presentations
   * Financials & Filings
     * SEC Filings
     * Annual Reports and Proxies
   * Corporate Governance
   * Stock Information
     * Historic Stock Lookup
   * Investors FAQs
 * Contact

 * Investors
   * Overview
   * Press Releases
   * Events & Presentations
   * Financial & Filings
   * Corporate Governance
   * Stock Information
   * Investors FAQs


INVESTORS


CORPORATE PROFILE

We are a biopharmaceutical company dedicated to the development of programmed
cellular immunotherapies. Our pipeline is comprised of cell-based therapies for
cancer and immune disorders. Our cellular immunotherapies are based on our novel
ex vivo cell programming approach, which we apply to modulate the therapeutic
function and direct the fate of hematopoietic cells.


PRESS RELEASES

 * Dec 13 2022
   Dec132022
   Summary ToggleFate Therapeutics Features Multiple Novel Approaches to
   Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell
   Therapies at 2022 ASH Annual Meeting
   Read All »
 * Dec 10 2022
   Dec102022
   Summary ToggleFate Therapeutics Highlights iPSC-derived, Off-the-shelf CAR NK
   Cell Programs for Multiple Myeloma at 2022 ASH Annual Meeting
   Read All »




EVENTS & PRESENTATIONS

 * Nov292022
   November 29, 2022 at  12:00 PM EST
   November 29, 2022
   12:00 PM EST
   
   
   PIPER SANDLER 34TH ANNUAL HEALTHCARE CONFERENCE
   
   Read All »
 * Nov162022
   November 16, 2022 at  7:55 AM EST
   November 16, 2022
   7:55 AM EST
   
   
   JEFFERIES LONDON HEALTHCARE CONFERENCE
   
   Read All »
 * Nov112022
   November 11, 2022 at  2:10 PM EST
   November 11, 2022
   2:10 PM EST
   
   
   COWEN 6TH ANNUAL IO NEXT SUMMIT
   
   Read All »
 * Nov032022
   November 3, 2022 at  5:00 PM EDT
   November 3, 2022
   5:00 PM EDT
   
   
   THIRD QUARTER 2022 FINANCIAL RESULTS
   
   Read All »





STOCK QUOTE

Price


$10.20

Change

-0.81

High


$11.07

View Details


STOCK CHART

 * 3 mo.
 * 6 mo.
 * 1 yr.






SHAREHOLDER TOOLS

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search



 * Facebook
 * LinkedIn
 * Twitter
 * RSS



© 2022 Fate Therapeutics | 3535 General Atomics Court, Suite 200, San Diego
92121 | 866.875.1833 | LEGAL


MENU
 * About Us
   * Our Mission
   * Our Cells of Interest
   * Management
   * Board of Directors
 * Pipeline
   * Overview
   * Immuno-Oncology Candidates
     * FT500
     * FT516
     * FT596
     * FT538
     * FT576
     * FT819
   * Immuno-Regulation Candidates
     * ProTmune™
     * FT301
 * Science
   * Ex Vivo Cell Modulation
   * iPSC Platform
   * Manufacturing
   * Publications
 * Collaborations
 * Join Our Team
   * Vision, Mission, Values
   * Working at Fate
   * Career Opportunities
 * Investors
   * Overview
   * Press Releases
   * Events & Presentations
   * Financials & Filings
     * SEC Filings
     * Annual Reports and Proxies
   * Corporate Governance
   * Stock Information
     * Historic Stock Lookup
   * Investors FAQs
 * Contact